Earth Life Sciences Inc.
CLTS
$0.00
$0.000.00%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 18.50K | 317.40K | 30.70K | 13.20K | 16.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.50K | 317.40K | 30.70K | 13.20K | 16.80K |
| Operating Income | -18.50K | -317.40K | -30.70K | -13.20K | -16.80K |
| Income Before Tax | -20.90K | -322.00K | -35.80K | -18.50K | -22.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.90K | -322.00K | -35.80K | -18.50K | -22.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.90K | -322.00K | -35.80K | -18.50K | -22.40K |
| EBIT | -18.50K | -317.40K | -30.70K | -13.20K | -16.80K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 970.68M | 976.46M | 960.47M | 473.52M | 494.65M |
| Average Diluted Shares Outstanding | 970.68M | 976.46M | 960.47M | 473.52M | 494.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
